A comparative study on culture conditions and routine expansion of amniotic fluid-derived mesenchymal progenitor cells

Fetal Diagnosis and Therapy

Volumn 34, Issue 4, 2013, Pages 225-235

  Gucciardo, L ^a   Ochsenbein Kolble N ^a   Ozog, Y ^a   Verbist, G ^a   Van Duppen, V ^a   Fryns, J P ^a   Lories, R ^a   Deprest, J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Amniotic fluid; Cell culture conditions; Cells; Characterization; Mesenchymal features; Self renewal and differentiation abilities

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; BETA1 INTEGRIN; ENDOGLIN; EPIDERMAL GROWTH FACTOR; FIBRONECTIN; GELATIN; HERMES ANTIGEN; HLA ANTIGEN; HLA DR ANTIGEN; INSULIN; LIOTHYRONINE; POLYSTYRENE; TRANSFERRIN; CELL SURFACE MARKER;

ADHERENT CELL; AMNIOTIC FLUID CELL; ARTICLE; BONE DEVELOPMENT; CELL DENSITY; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; CELL RENEWAL; CELL SIZE; CELL STIMULATION; CELL STRUCTURE; COMPARATIVE STUDY; CYTOGENETICS; FEASIBILITY STUDY; FETUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; PHENOTYPE; PRIORITY JOURNAL; SPINDLE CELL; STEM CELL EXPANSION; AMNIOTIC FLUID STEM CELL; LARGE SCALE PRODUCTION; STEM CELL CULTURE;

AMNIOTIC FLUID; ANIMALS; CATTLE; CELL COUNT; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CULTURE MEDIA; FEMALE; HUMANS; KARYOTYPING; MESENCHYMAL STROMAL CELLS; PREGNANCY;

EID: 84890114296     PISSN: 10153837     EISSN: 14219964     Source Type: Journal    
DOI: 10.1159/000354895     Document Type: Article

References (46)

1. Friedenstein AJ, Chailakhjan RK, Lalykina KS: The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970; 3: 393-403.
2. Friedenstein AJ, Gorskaja JF, Kulagina NN: Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976; 4: 267-274.
3. Pittenger MF, Mackay AM, Beck SC, et al: Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
4. Prockop DJ: Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71-74.
5. Minguell JJ, Erices A, Conget P: Mesenchymal stem cells. Exp Biol Med (Maywood) 2001; 226: 507-520.
6. Le Blanc K, Pittenger M: Mesenchymal stem cells: progress toward promise. Cytotherapy 2005; 7: 36-45.
7. Benvenuti S, Saccardi R, Luciani P, et al: Neuronal differentiation of human mesenchymal stem cells: changes in the expression of the Alzheimer's disease-related gene seladin-1. Exp Cell Res 2006; 312: 2592-2604.
8. Aggarwal S, Pittenger MF: Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815-1822.
9. Le Blanc K, Ringden O: Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 321-334.
10. Le Blanc K, Ringden O: Mesenchymal stem cells: properties and role in clinical bone marrow transplantation. Curr Opin Immunol 2006; 18: 586-591.
11. Bhatia M, Wang JC, Kapp U, et al: Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci USA 1997; 94: 5320-5325.
12. Osawa M, Hanada K, Hamada H, et al: Longterm lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996; 273: 242-245.
13. Chen SL, Fang WW, Ye F, et al: Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004; 94: 92-95.
14. Mazzini L, Mareschi K, Ferrero I, et al: Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis. Neurol Res 2006; 28: 523-526.
15. Koc ON, Day J, Nieder M, et al: Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 2002; 30: 215-222.
16. Javazon EH, Beggs KJ, Flake AW: Mesenchymal stem cells: paradoxes of passaging. Exp Hematol 2004; 32: 414-425.
17. Siegel N, Rosner M, Hanneder M, et al: Human amniotic fluid stem cells: a new perspective. Amino Acids 2008; 35: 291-293.
18. Guillot PV, Abass O, Bassett JH, et al: Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice. Blood 2008; 111: 1717-1725.
19. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al: Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999; 5: 309-313.
20. Montemurro T, Andriolo G, Montelatici E, et al: Differentiation and migration properties of human fetal umbilical cord perivascular cells: potential for lung repair. J Cell Mol Med 2011; 15: 796-808.
21. Turner CG, Fauza DO: Fetal tissue engineering. Clin Perinatol 2009; 36: 473-488, xii.
22. Gucciardo L, Lories R, Ochsenbein-Kolble N, et al: Fetal mesenchymal stem cells: isolation, properties and potential use in perinatology and regenerative medicine. BJOG 2009; 116: 166-172.
23. Fuchs JR, Kaviani A, Oh JT, et al: Diaphragmatic reconstruction with autologous tendon engineered from mesenchymal amniocytes. J Pediatr Surg 2004; 39: 834-838, discussion 834-838.
24. Kunisaki SM, Fuchs JR, Kaviani A, et al: Diaphragmatic repair through fetal tissue engineering: a comparison between mesenchymal amniocyte- and myoblast-based constructs. J Pediatr Surg 2006; 41: 34-39, discussion 34-39.
25. Fauza DO, Fishman SJ, Mehegan K, et al: Videofetoscopically assisted fetal tissue engineering: bladder augmentation. J Pediatr Surg 1998; 33: 7-12.
26. O'Donoghue K, Fisk NM: Fetal stem cells. Best Pract Res Clin Obstet Gynaecol 2004; 18: 853-875.
27. In't Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al: Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004; 22: 1338-1345.
28. In't Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al: Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 2003; 102: 1548-1549.
29. Tsai MS, Lee JL, Chang YJ, et al: Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 2004; 19: 1450-1456.
30. Bossolasco P, Montemurro T, Cova L, et al: Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential. Cell Res 2006; 16: 329-336.
31. Parolini O, Alviano F, Bagnara GP, et al: Concise review: isolation and characterization of cells from human term placenta - outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 2008; 26: 300-311.
32. Abdulrazzak H, De Coppi P, Guillot PV: Therapeutic potential of amniotic fluid stem cells. Curr Stem Cell Res Ther 2013; 8: 117-124.
33. Trohatou O, Anagnou NP, Roubelakis MG: Human amniotic fluid stem cells as an attractive tool for clinical applications. Curr Stem Cell Res Ther 2013; 8: 125-132.
34. Campagnoli C, Roberts IA, Kumar S, et al: Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001; 98: 2396-2402.
35. Portmann-Lanz CB, Schoeberlein A, Huber A, et al: Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. Am J Obstet Gynecol 2006; 194: 664-673.
36. Reyes M, Lund T, Lenvik T, et al: Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001; 98: 2615-2625.
37. Ochsenbein-Kolble N, Bilic G, Hall H, et al: Inducing proliferation of human amnion epithelial and mesenchymal cells for prospective engineering of membrane repair. J Perinat Med 2003; 31: 287-294.
38. De Bari C, Dell'Accio F, Tylzanowski P, et al: Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 2001; 44: 1928-1942.
39. De Coppi P, Bartsch G Jr, Siddiqui MM, et al: Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007; 25: 100-106.
40. van der Valk J, Mellor D, Brands R, et al: The humane collection of fetal bovine serum and possibilities for serum-free cell and tissue culture. Toxicol In Vitro 2004; 18: 1-12.
41. Kim J, Lee Y, Kim H, et al: Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif 2007; 40: 75-90.
42. Baxter MA, Wynn RF, Jowitt SN, et al: Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 2004; 22: 675-682.
43. Bonab MM, Alimoghaddam K, Talebian F, et al: Aging of mesenchymal stem cell in vitro. BMC Cell Biol 2006; 7: 14.
44. Muraglia A, Cancedda R, Quarto R: Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000; 113: 1161-1166.
45. Digirolamo CM, Stokes D, Colter D, et al: Propagation and senescence of human marrow stromal cells in culture: a simple colonyforming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 1999; 107: 275-281.
46. Zia S, Toelen J, da Cunha MM, et al: Routine clonal expansion of mesenchymal stem cells derived from amniotic fluid for perinatal applications. Prenat Diagn 2013;23:1-8. doi: 10.1002/pd.4162. [Epub ahead of print]